首页|人脐带间充质干细胞条件培养基治疗大鼠间质性膀胱炎的实验研究

人脐带间充质干细胞条件培养基治疗大鼠间质性膀胱炎的实验研究

扫码查看
目的 探讨人脐带间充质干细胞条件培养基(HUC-MSC-CM)膀胱灌注治疗大鼠间质性膀胱炎(IC)的疗效.方法 30只成年SD雌性大鼠采用随机数字表法平均分为3组,每组10只,IC组和MSC-CM组采用环磷酰胺腹腔注射构建间质性膀胱炎模型,空白组腹腔注射等体积生理盐水;建模成功后MSC-CM组行HUC-MSC-CM膀胱灌注治疗,每3d 1次,持续1周,空白组及IC组采用等体积生理盐水膀胱灌注处理;治疗完成后,分析比较各组大鼠排尿间隔、膀胱组织炎性因子[白细胞介素(IL)-1β、IL-6、肿瘤坏死因子(TNF)-α]浓度、病理评分、肥大细胞计数、凋亡细胞计数等指标.应用独立样本t检验进行组间比较.结果 MSC-CM组尿动力学参数中排尿间隔大于IC组[(254.40±4.75)s 比(191.90±4.95)s,t=9.111,P<0.05],MSC-CM 组膀胱匀浆炎性因子(IL-1β、lL-6、TNF-α)浓度低于 IC 组[(116.80±8.34)pg/ml 比(202.00±10.79)pg/ml、(177.20±54.22)pg/ml 比(283.80±42.86)pg/ml、(51.46±8.68)pg/ml 比(70.43±14.53)pg/ml,t=6…….251、4.876、3.545,P<0.05],MSC-CM组病理评分、肥大细胞计数、凋亡细胞计数低于1C组[(9.20±0.49)分比(12.40±0.52)分、(7.50±0.65)个比(11.50±0.54)个、(17.00±1.23)个比(28.80±2.13)个,t=4.476、4.707、4.793,P<0.05].结论 人脐带间充质干细胞条件培养基膀胱灌注能有效治疗大鼠间质性膀胱炎.
Experimental study of human umbilical cord mesenchymal stem cell conditioned medium for treat-ment of rat interstitial cystitis
Objective To investigate the efficacy of human umbilical cord mesenchymal stem cell conditioned media(HUC-MSC-CM)bladder perfusion in rat interstitial cystitis(IC).Methods 30 adult SD female rats were randomly averaged into three groups by random digital table method,the IC and MSC-CM groups constructed a model of interstitial cystitis using cyclophosphamide intraperitoneal injection,the blank group was intraperitoneally injected with an equal volume of normal saline;The MSC-CM group underwent HUC-MSC-CM bladder perfusion therapy after successful modeling,every 3 days for 1 week,the blank group and the IC group were treated with equal volume normal saline bladder perfusion;after treat-ment,the urination interval,concentration of bladder inflammatory factor[interleukin(IL)-1 β,IL-6,tumor necrosis factor-α(TNF-α)],degree of pathological inflammation,mast cell count,and apoptotic cell count were analyzed and compared.The independent sample t test was used for comparison between groups.Results The urination interral in the MSC-CM group was larger than that in the IC group[(254.40±4.75)s vs.(191.90±4.95)s,t=9.111,P<0.05],the concentration of bladder homoge-nization of inflammatory factors(IL-1β,IL-6,TNF-α)was lower in the MSC-CM group than that in the IC group[(116.80±8.34)pg/ml vs.(202.00±10.79)pg/ml,(177.20±54.22)pg/ml vs.(283.80±42.86)pg/ml,(51.46±8.68)pg/ml vs.(70.43±14.53)pg/ml,t=6.251,4.876,3.545,P<0.05],and the pathological score,mast cell count,and apoptotic cell count were lower in the MSC-CM group than those in the IC group[(9.20±0.49)cells vs.(12.40±0.52)cells,(7.50±0.65)cells vs.(11.50±0.54)cells,(17.00±1.23)cells vs.(28.80±2.13)cells,t=4.476,4.707,4.793,P<0.05)].Conclusion Human umbilical cord mesenchymal stem cells conditioned medium can effectively treat interstitial cystitis in rats.

Stem cellsConditioned mediumInterstitial cystitisRat

谢俊聪、刘柏隆、张弛、周祥福

展开 >

中山大学附属第三医院泌尿外科,广州 510630

干细胞 条件培养基 间质性膀胱炎 大鼠

2024

中华实验外科杂志
中华医学会

中华实验外科杂志

CSTPCD
影响因子:0.759
ISSN:1001-9030
年,卷(期):2024.41(12)